Skip Navigation LinksHome > November 2014 - Volume 20 - Issue 6 > Update on hypersomnias of central origin
Current Opinion in Pulmonary Medicine:
doi: 10.1097/MCP.0000000000000098
SLEEP AND RESPIRATORY NEUROBIOLOGY: Edited by Lee K. Brown and Adrian Williams

Update on hypersomnias of central origin

Drakatos, Panagisa; Leschziner, Guy D.a,b,c

Editor's Choice
Collapse Box

Abstract

Purpose of review

To describe the multiple clinical aspects of hypersomnias of central origin. Emphasis is given to the new pathophysiological pathways and treatment options described in the current literature.

Recent findings

Narcolepsy is the most recognized of the hypersomnias of central origin. Hypocretin deficiency appears to underlie narcolepsy with cataplexy, and infections and vaccinations have been associated with disease onset. Targeted therapeutic approaches are currently underway. A putative naturally occurring constituent in the cerebrospinal fluid of patients with non-narcoleptic primary hypersomnias, able to stimulate γ-aminobutyric acid alpha receptors and induce sleep, has recently been postulated. Neuroimaging has also provided more insight into the pathophysiology of Kleine–Levin syndrome. Sleep deprivation is currently recognized as a major differential diagnosis.

Summary

Excessive daytime sleepiness is the cardinal symptom of the hypersomnias of central origin, with major impact on the quality of life. It is important that clinicians be able to recognize these conditions, so that appropriate management or onward referral is expedited.

© 2014 Wolters Kluwer Health | Lippincott Williams & Wilkins

Login

Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.